0001246360-17-002524.txt : 20170808 0001246360-17-002524.hdr.sgml : 20170808 20170808183511 ACCESSION NUMBER: 0001246360-17-002524 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170807 FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turk Joseph E Jr CENTRAL INDEX KEY: 0001341403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 171016034 MAIL ADDRESS: STREET 1: NXSTAGE MEDICAL INC STREET 2: 439 SOUTH UNION STREET 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 4 1 form.xml PRIMARY DOCUMENT X0306 4 2017-08-07 false 0001333170 NxStage Medical, Inc. NXTM 0001341403 Turk Joseph E Jr 350 MERRIMACK STREET LAWRENCE MA 01843 false true false false President Common Stock 2017-08-07 4 M false 7000 11.03 A 82903 D Common Stock 2017-08-07 4 M false 12000 14.66 A 94903 D Common Stock 2017-08-07 4 M false 2669 18.48 A 97572 D Common Stock 2017-08-07 4 M false 2331 18.59 A 99903 D Common Stock 2017-08-07 4 S false 6000 29.66 D 93903 D Common Stock 2017-08-07 4 S false 18000 29.63 D 75903 D Stock Option (Right to Buy) 11.03 2017-08-07 4 M false 7000 0 D 2013-04-04 2023-03-03 Common Stock 7000 25897 D Stock Option (Right to Buy) 14.66 2017-08-07 4 M false 12000 0 D 2014-04-10 2024-03-09 Common Stock 12000 36958 D Stock Option (Right to Buy) 18.48 2017-08-07 4 M false 2669 0 D 2012-04-09 2019-03-08 Common Stock 2669 7542 D Stock Option (Right to Buy) 18.59 2017-08-07 4 M false 2331 0 D 2011-06-27 2018-05-26 Common Stock 2331 5392 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. /s/ Aras Lapinskas, attorney-in-fact for Joseph Turk 2017-08-08